Constellium raised at J.P. Morgan as earnings beat shows solid growth opportunities

Constellium CSTM fell 1.2% despite a J.P. Morgan upgrade to Overweight with a $35 target. Q3 adjusted EBITDA was $280M, beating expectations, and full-year EBITDA guidance was raised by 5% to $1.03B-$1.06B. J.P. Morgan cites strong growth opportunities in Automotive Structures & Industry segments.

Original reporting
Published Oct 29, 2026, 6:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 7:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Constellium raised at J.P. Morgan as earnings beat shows solid growth opportunities — source image
Decision brief

The 30-second read

$CSTMBullishHigh
01

Why it matters

The earnings beat and analyst upgrade provide a fresh catalyst for the stock.

02

Market read

New earnings data and upgrade create a short-term buying opportunity.

03

What to watch

Future ABS share gains may be less than expected, tempering growth.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Constellium reported better-than-expected adjusted EBITDA of $280M and lifted FY EBITDA guidance by 5%.

Company-level read

Ticker impact

$CSTMBullishHigh confidence
Context

J.P. Morgan upgraded Constellium to Overweight with a $35 price target and raised full-year EBITDA guidance after the Q3 earnings beat.

Expected impact

likely upward pressure as the market prices in the upgrade and stronger guidance

Evidence & confidence

Analyst upgrade to Overweight and a $35 target signal confidence in earnings momentum.

Market effects

Positive for aluminum and aerospace suppliers as demand outlook improves.

May boost North American industrial stocks.

Supports broader materials sector sentiment.

Counterpoint

Potential headwinds from scrap spread compression could limit upside.

Key entities

  • Constellium

    Aluminum products manufacturer

  • J.P. Morgan

    Upgraded Constellium to Overweight

Related articles

$EROMed

Five Metals Producers Trade Higher as Gold, Silver and Copper Futures Pull Back

Five metals producers (Ero Copper, Nexa Resources, Constellium, Algoma Steel, New Found Gold) traded higher despite pullbacks in gold, silver, and copper futures. Ero Copper reported record Q3 results with copper and gold production increases. Nexa Resources saw a 62% YoY rise in adjusted EBITDA. Constellium raised its 2026 guidance. Algoma Steel transitioned to electric arc furnace steelmaking. New Found Gold updated its Queensway project assessment.

$CSTMHigh

JPMorgan upgrades Constellium stock rating on earnings beat

JPMorgan upgraded Constellium (CSTM) to Overweight, raising its price target to $35.00. The move follows CSTM's Q3 earnings beat, with adjusted EBITDA of $280M, 12% above estimates. The company also raised its fiscal 2026 EBITDA guidance. CSTM's stock has declined 16% in the past three months, despite strong Q3 results and a positive outlook on demand.

$CSTMMed

Constellium reports strong 2026 results

Constellium reported Q3 2026 revenue of $2.6B, up 22% YoY, and net income of $119M, up $31M. Shipments fell 1% to 368,000 tonnes. CEO Ingrid Joerg attributed growth to operational focus and market dynamics. Adjusted EBITDA rose to $276M, up $41M. Nine-month revenue reached $7.8B, up 26%, with net income at $463M, up $301M.

$CSTMMed

Constellium SE Q3 2026 Earnings Call Summary

Constellium SE reported record Q3 2026 earnings, driven by strong aerospace and North American automotive markets. The company raised 2026 EBITDA guidance to $1.03B-$1.06B. Management expects significant aerospace growth in 2027, supported by OEM build rates and tight market capacity. Strategic investments in recycling and new facilities are expected to provide cost advantages and meet growing demand.

$CSTMHighAI 8/10

Constellium (CSTM) Q3 2026 Earnings Call Transcript

Constellium (CSTM) reported Q3 2026 earnings, with revenue up 22% YoY to $2.6B and adjusted EBITDA up 17% to $276M. The company raised its full-year outlook, citing strong performance and favorable market dynamics. It also discussed manageable impacts from the Middle East conflict. Free cash flow was $128M, and $30M was returned to shareholders via share repurchases.

$CSTMMed

Constellium Q3 Earnings Call Highlights

Constellium (CSTM) reported Q3 free cash flow of $128M, reducing net debt to $1.7B. Adjusted EBITDA rose in Aerospace & Transportation and Packaging & Automotive, but fell in Automotive Structures & Industry. The company raised its 2026 EBITDA outlook to $1.03B-$1.06B and expects free cash flow to exceed $300M.